Pharmaceutical News

RSS

Tablets which help recovering alcoholics stay off the drink

The United States Food and Drug Administration has approved Campral (acamprosate calcium) tablets which help recovering alcoholics to stay of the drink. Campral is manufactured by Forest Laboratories and Merck of Darmstadt, Germany.

29 Jul 2004

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

A study by the Kaiser Family Foundation shows that the Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs. In its report, the organization finds that prices have not been fluctuating as much as had been feared.

29 Jul 2004

Philadelphia diet drug trial completed

Wyeth has announced that the jury in the case of Rhonda Istnick and Henry Clepper v. Wyeth, et al. rendered its decision, finding in favor of the Company in the case brought by Ms. Istnick, while awarding Mr. Clepper compensatory damages in the amount of $48,000.

29 Jul 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

The Pharmacy Care Alliance has announced that for the first seven weeks of its discount card program, Medicare beneficiaries saved an average of 40 percent on generic drugs and 23 percent on brand drugs when compared to retail pharmacy cash prices. Medicare beneficiaries in all U.S. states have used the Pharmacy Care Alliance card since June 1.

29 Jul 2004

Research collaboration to discover novel oral drugs for the treatment of viral infections

Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.

29 Jul 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

BMA ready to support overworked doctors who decide to take legal action

With the deadline for legal limits on junior doctors' hours only three days away, the BMA warns that it is ready to support overworked doctors who decide to take legal action.

28 Jul 2004

Pharmaceutical Benefits Scheme (PBS) medicines available faster

The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.

27 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

Janssen Pharmaceutica, the maker of RISPERDAL® (risperidone), the most frequently prescribed antipsychotic medication in the U.S., has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®.

26 Jul 2004

The Internet has become the street corner for many drug users and traffickers

Operation Web Tryp investigated Internet websites distributing highly dangerous designer drug analogues under the guise of “research chemicals” primarily shipped to the U.S. from China and India. These websites are known to have thousands of customers worldwide.

26 Jul 2004

GlaxoSmithKline to stand trial on AIDS drugs

The Competition Tribunal of South Africa agreed late last week to hear the complaint filed by individual South Africans and AIDS Healthcare Foundation, a nongovernmental organization that operates a free AIDS treatment clinic in Durban, that British drug maker GlaxoSmithKline illegally excessively priced AIDS drugs in violation of the South African Competition Act.

26 Jul 2004

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.

23 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Medicare could eliminate the coverage gap in its prescription drug benefit if it paid pharmaceutical prices comparable to those paid by citizens of Canada, the United Kingdom and France, according to a report by researchers from the Johns Hopkins Bloomberg School of Public Health and Pennsylvania State University

21 Jul 2004

Court ruling favors State over pharmaceutical manufacturers

Nevada Attorney General Brian Sandoval yesterday announced that Washoe County District Court Judge Steven R. Kosach has issued an important ruling in Nevada's Average Wholesale Price (AWP) litigation against numerous pharmaceutical manufacturers including Abbott Labs, Baxter, Bristol-Myers Squibb, Dey, GlaxoSmithKline, and Pharmacia.

21 Jul 2004

Pharmaceutical News

Tablets which help recovering alcoholics stay off the drink

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

Philadelphia diet drug trial completed

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

Research collaboration to discover novel oral drugs for the treatment of viral infections

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

BMA ready to support overworked doctors who decide to take legal action

Pharmaceutical Benefits Scheme (PBS) medicines available faster

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

The Internet has become the street corner for many drug users and traffickers

GlaxoSmithKline to stand trial on AIDS drugs

Plan B has been shown to reduce the risk of pregnancy by 89 percent

New cream treatment for common form of skin cancer

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Court ruling favors State over pharmaceutical manufacturers

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News